Form 4 holding
Director
Marker Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 325,370
- Estimated value
- $1,041,184
- Report date
- 23 Dec 2024
- Price
- $3.20
- Ownership
- Indirect
Steve Elms - Director at Marker Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- MRKR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Steve Elms since 08 Aug 2025
Reported holdings for Steve Elms in Marker Therapeutics, Inc.
Form 4 holding
Director
Marker Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,968
- Estimated value
- $9,498
- Report date
- 23 Dec 2024
- Price
- $3.20
- Ownership
- Direct
Form 4 holding
Director
Marker Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 137,330
- Estimated value
- Report date
- 17 Nov 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Steve Elms in Marker Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.